GME Geratherm Medical AG

XETRA · DE · Healthcare · Medical Devices · geratherm.com

2.110EUR-2.77%Mkt Cap: 12.41M $P/E: —Today

Geratherm Medical AG, a medical technology company, develops, produces, and markets medical products for measuring vital data in Germany. It operates through Healthcare Diagnostic, Respiratory, and Incubator Systems segm…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap12.41M USD

Enterprise Value5.07M USD

Revenue (TTM)15.19M USD

Gross Profit11.45M USD

Net Income (TTM)-890.20K USD

Revenue/Share3.14 EUR

Last Price2.110 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees136

CountryDE

SectorHealthcare

IndustryMedical Devices

ISINDE0005495626

Valuation

P/E (Trailing)—

P/E (Forward)108.50

PEG0.74

EV/EBITDA-24.11

EV/Revenue0.33

P/S0.84

P/B0.60

EPS (TTM)-0.19

EPS (Forward)0.02

52W Range

2.0701% of range7.880

52W High7.880 EUR

52W Low2.070 EUR

Profitability

Gross Margin65.70%

Oper. Margin-11.81%

EBITDA Margin-1.38%

Profit Margin-5.11%

ROE-4.17%

ROA-3.15%

Growth

Revenue Growth-12.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF1.42M USD

CapEx (TTM)643.48K USD

FCF Margin5.58%

FCF Yield6.83%

Net Debt-7.20M USD

Net Debt/EBITDA34.26

Balance Sheet

Debt/Equity0.13

Current Ratio4.57

Quick Ratio2.90

Book Value/Sh3.63 EUR

Cash/Share1.63 EUR

Dividends

Fwd Div Rate0.10 EUR

Trail. Div Rate0.10 EUR

Div. Yield4.61%

5Y Avg Yield2.83%

Payout Ratio28.57%

Ex-Div DateJul 27, 2026

Pay Date—

Analyst Consensus

Rating—

Target (Mean)4.000 EUR

Upside (mean)+89.6%

Target Range4.000 EUR – 4.000 EUR

# Analysts1

Ownership

Shares Out.5.41M

Float1.41M

Insiders72.47%

Institutions0.14%

Technical

SMA 502.498 (-15.5%)

SMA 2002.702 (-21.9%)

Beta0.41

S&P 52W Chg14.58%

Avg Vol (30d)1.00K

Avg Vol (10d)630

Technical Indicators

RSI (14)26.0

MACD-0.0876

MACD Signal-0.0672

MACD Hist.-0.0204

BB Upper2.589 EUR

BB Middle2.381 EUR

BB Lower2.173 EUR

BB Width17.51%

ATR (14)0.0738 EUR

Vol Ratio (20d)3.14x